Literature DB >> 22089103

Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.

Tsuneo Konta1, Ami Ikeda, Kazunobu Ichikawa, Shouichi Fujimoto, Kunitoshi Iseki, Toshiki Moriyama, Kunihiro Yamagata, Kazuhiko Tsuruya, Hideaki Yoshida, Koichi Asahi, Issei Kurahashi, Yasuo Ohashi, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: Hypertension is a key risk factor for adverse renal outcomes in chronic kidney disease (CKD), and strict blood pressure control is recommended to halt its progression. This study assessed blood pressure control in the Japanese CKD population.
METHODS: We used a nationwide database of 250,130 subjects (aged 20-88), including 45,845 CKD subjects (18.3%), participated in an annual health check, "The Specific Health Check and Guidance in Japan," and examined the relationship between CKD status and blood pressure. Blood pressures were measured in sitting position by trained staff, and target blood pressure for CKD subjects was defined as systolic (SBP)/diastolic blood pressure (DBP) <130/80 mm Hg.
RESULTS: In total population, CKD subjects had a higher prevalence of hypertension (58.0% vs. 41.8%, P < 0.001) and a higher proportion with antihypertensive medication (42.4% vs. 26.7%, P < 0.001), compared with non-CKD subjects. The proportion of subjects achieving target blood pressure was significantly lower among total CKD subjects than among total non-CKD subjects (34.6% vs. 43.8%, P ≤ 0.001). Among CKD subjects, these proportions were especially low in those with stage 4-5 (24.3-27.5%), those on antihypertensive medication (21.6%) and those with proteinuria ≥2± (21.3%). Logistic regression analysis showed that independent factors for high-blood pressure in CKD subjects were age, male gender, alcohol consumption, nonsmoking, diabetes, dyslipidemia, obesity, proteinuria, and antihypertensive medication.
CONCLUSIONS: Blood pressure control was inadequate in the majority of Japanese CKD subjects, despite antihypertensive treatment. More aggressive efforts to achieve target blood pressures among CKD subjects are recommended.
© 2012 American Journal of Hypertension, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089103     DOI: 10.1038/ajh.2011.217

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  15 in total

1.  Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort.

Authors:  Aya Nakajima; Kenichi Tanaka; Hirotaka Saito; Tsuyoshi Iwasaki; Akira Oda; Makoto Kanno; Michio Shimabukuro; Koichi Asahi; Tsuyoshi Watanabe; Junichiro James Kazama
Journal:  Clin Exp Nephrol       Date:  2019-12-26       Impact factor: 2.801

2.  The healthcare burden of hypertension in Asia.

Authors:  Chun-Na Jin; Cheuk-Man Yu; Jing-Ping Sun; Fang Fang; Yong-Na Wen; Ming Liu; Alex Pui-Wai Lee
Journal:  Heart Asia       Date:  2013-11-19

Review 3.  Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Curr Hypertens Rep       Date:  2019-01-10       Impact factor: 5.369

4.  Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.

Authors:  Kunitoshi Iseki; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Tsuneo Konta; Masato Kasahara; Yugo Shibagaki; Hisako Yoshida; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

5.  An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey.

Authors:  Toshihiro Ishigami; Ryohei Yamamoto; Yasuyuki Nagasawa; Yoshitaka Isaka; Hiromi Rakugi; Kunitoshi Iseki; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Shouichi Fujimoto; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Toshiki Moriyama; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-02-04       Impact factor: 2.801

6.  Dipstick proteinuria and all-cause mortality among the general population.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2018-06-05       Impact factor: 2.801

7.  Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction.

Authors:  Sadayoshi Ito; Minoru Satoh; Yuko Tamaki; Hiromi Gotou; Alan Charney; Naoko Okino; Mizuki Akahori; Jack Zhang
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

Review 8.  Traditional Risk Factors for Stroke in East Asia.

Authors:  Young Dae Kim; Yo Han Jung; Gustavo Saposnik
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

9.  A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease.

Authors:  Wen Zhang; Wei Shi; Zhangsuo Liu; Yong Gu; Qinkai Chen; Weijie Yuan; Yanlin Zhang; Li Gong; Rong Zhou; Mingxu Li; Hong Cheng; Jian Liu; Jun Cen; Chaoxing Huang; Yeping Ren; Peiju Mao; Changying Xing; Fuyuan Hong; Dongsheng Jiang; Li Wang; Gang Xu; Jianshe Liu; Nan Chen
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

10.  UMOD as a susceptibility gene for end-stage renal disease.

Authors:  Anna Reznichenko; Carsten A Böger; Harold Snieder; Jacob van den Born; Martin H de Borst; Jeffrey Damman; Marcory C R F van Dijk; Harry van Goor; Bouke G Hepkema; Jan-Luuk Hillebrands; Henri G D Leuvenink; Jan Niesing; Stephan J L Bakker; Marc Seelen; Gerjan Navis
Journal:  BMC Med Genet       Date:  2012-09-05       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.